Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation

Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia

NCT05335226 ·Status: UNKNOWN ·Phase: NA

Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation

NCT06715046 ·Status: RECRUITING

Evolution of the Energy Expenditure During Hematopoietic Stem Cell Transplantation

NCT04535570 ·Status: COMPLETED

National Marrow Donor Program Long-Term Donor Follow-Up

NCT01362179 ·Status: COMPLETED

Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation

NCT04146870 ·Status: RECRUITING

Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA

NCT07299123 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2

Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population

NCT03482154 ·Status: COMPLETED

Role of aGVHD Biomarkers on aGVHD Risks

NCT04284904 ·Status: COMPLETED

Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure

NCT01763099 ·Status: UNKNOWN ·Phase: PHASE2

Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients

NCT02623309 ·Status: COMPLETED ·Phase: PHASE3

Umbilical Cord Mesenchymal Stem Cells as First-line Treatment for Patients With Acute Graft Versus Host Disease

NCT05531266 ·Status: UNKNOWN ·Phase: NA

Allogenic Bone Marrow Stem Cell Transplantation in Liver Failure

NCT01221454 ·Status: UNKNOWN ·Phase: PHASE2

Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell Transplantation

NCT05250362 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases

NCT06294691 ·Status: RECRUITING ·Phase: PHASE3

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

NCT01890486 ·Status: RECRUITING

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT

NCT07047456 ·Status: RECRUITING ·Phase: PHASE3

Biomarker Study for Prediction of aGVHD

NCT03614143 ·Status: UNKNOWN

Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

NCT00725062 ·Status: TERMINATED ·Phase: PHASE1

Intrabone Infusion of Cord Blood in Adults With Hematological Malignancies

NCT00886522 ·Status: COMPLETED ·Phase: PHASE2

A Follow-up Study in Patients With Inherited Metabolic Disorders (IMD) Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) With MGTA-456

NCT04008849 ·Status: TERMINATED

Graft-versus-host Disease Associated Myelosuppression

NCT02829216 ·Status: UNKNOWN

Observational Study of Iron Overload in Stem Cell Transplantation

NCT00954720 ·Status: COMPLETED

Evaluation of Malglycemia Via Continuous Glucose Monitoring in the Pediatric HSCT Population

NCT03037671 ·Status: COMPLETED

Safety and Efficacy of Human Bone Marrow Stem Cells for Treatment of HBV-related Liver Cirrhosis

NCT01724697 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant

NCT01763086 ·Status: UNKNOWN ·Phase: PHASE2